CASE PRESENTATION ON

VERNAL KERATO CONJUNCTIVITIS(VKC)

PRESENTED BY:

NUTHAN.V

Y12PHD0430

VI PHARM-D

INTRODUCTION

• VKC is a bilateral chronic inflammation of the conjunctiva of the eye.

• It is more common in young boys. The disease affects children between 3 to 16

years of age though it may appear earlier than that and continue into adulthood.

• In the majority of cases, symptoms resolve at puberty.

• Limbal and palpebral vernal keratoconjunctivitis (VKC) are usually considered to

be different expressions of the same disease.

• Limbal VKC was distinguished from palpebral VKC by the development of

papillae at the limbus. Whereas, the palpebral form was distinguished by

presence of giant papillae on the upper tarsal conjunctiva.

• Patients showing both giant papillae and limbal papillae were classified as mixed.

• Although Horner-Trantas's dots are commonly associated with limbal papillae

they were not considered pathognomonic of limbal VKC because they have been

frequently reported at other sites.

INTRODUCTION…

• 1. This may start as

thickening &

opacification of limbus,

follicles, mucoid

nodules & trantas dots

can be observed.

• 2. Papillary

hypertrophy on

superior tarsus was

observed.

• 3. Papillae having

polygonal appearance

resembling “Cobbler

stones”.

1. 2.

3.

Limbal VKC & Palpebral VKC

PATIENT DEMOGRAPHICS:

• Age: 6 years

• Sex: Male

• Unit: Outpatient

• Weight: 20 kgs

• DOA : 6-9-17

CHIEF COMPLAINTS:

Redness of eyes since last night,

Itching, Irritation, Photosensitivity

NO EVIDENCE OF PMH/O

EXAMINATIONS

Detailed eye examination including:

A slit lamp (usually performed during

eye checkups to look for any diseases

or abnormalities in the anterior portion

of the eye, which includes the eyelids,

lashes, lens, conjunctiva, cornea, and

iris) or

ophthalmoscope(Fundoscopy to see

inside the fundus of the eye and other structures) examination

PROVISIONAL DIAGNOSIS

VERNAL KERATO CONJUNCTIVITS

PLAN FOR THERAPY

DRUG DOSE FREQUENCY DURATION

Opth. Moxifloxacin +

Dexamethasone

5mg/ 1mg 5 times a day

for a week

followed by tapering

frequency of dose

Opth. Hydroxypropylmethyl

cellulose

0.3% w/v 3 times a day For 6 months

Opth. Ketorolac tromethamine+

Olopatadine

4mg/ 1mg 2 times a day For 6 months

Oint. Polymyxin B+

Chloramphenicol+Dexamethaso

ne

1000 units/

10mg/ 1mg

At night For 2 weeks

Patient counselling

Patient guardian was counselled to :

• Use cold water to wash both the eyes.

• Using goggles to cover the eyes.

• Use Cold compress & ice packs to relieve pain and discomfort.

• Avoid touching eyes with hands.